NCT00947076View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions
Depression
Interventions
DRUG

Fluoxetine Hydrochloride Capsules, 40 mg (Geneva Pharmaceutical, Inc)

DRUG

Fluoxetine Hydrochloride Capsules, 40 mg (Prozac) (Eli Lilly)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY